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Abstract
"Unravelling the Induction and Development of Intramembranous Bones in the
Chicken Eye"
By: Kellie Duench
Bone development is a complex process, involving multiple tissues and hierarchical
inductive interactions. The study of skeletal development has focused on endochondral
bones while intramembranous bones (e.g. scleral ossicles) have received less attention.
Although, sonic hedgehog was recently demonstrated to be present during induction of
scleral ossicles, other signalling molecules are still unknown. Using in situ hybridization
and bead implantation I have demonstrated the presence or absence and the involvement
of candidate genes and gene families during the development of scleral ossicles.
Scleraxis, patched, as well as the bone morphogenetic protein (BMP) family of genes,
were found to be involved in the development of scleral ossicles. Conversely, it was
determined that indian hedgehog and msx2 are not present. This study has contributed to
unravelling the signals involved during the induction and subsequent development of





BCIP - 5-Bromo 4-Chloro 3'-
Indolyphosphate p-Toluidine salt
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1.0 Introduction
1.1 The skeleton: an introduction
Skeletal development is a complex, step-wise, hierarchal process. The skeleton is
made up of two main groups; appendicular and axial (Steele and Bramblet, 1988).
The axial skeleton consists of bones in line with the centre axis, the spine. Therefore,
the vertebral column, the ribs, and bones of the craniofacial skeleton including the
calvariae (intramembranous bones of the skull vault) are all part of this group. The
appendicular skeleton consists of all the bones in the appendages, lower limbs, upper
limbs, and the sockets/girdles that hold the limbs in place (pectoral and pelvic
girdles).
Within the axial skeleton, the bones of the craniofacial skeleton are derived from
neural crest cells that migrate from the neural tube and invade the craniofacial region,
to form the craniofacial mesenchyme. The mesenchyme is then involved in the
signalling and induction for a variety of craniofacial bones, such as calvaría, bones of
the jaw, and bones of the inner ear. Neural crest derived mesenchyme is not involved
in all types ofbone development. In the appendicular skeleton, the bones are typically
derived from the somatic lateral plate mesoderm (Hall, 2005).
In summary, the cells that give rise to these two skeletal systems are different
(mesoderm vs. neural crest derived). The processes by which these two skeletal
systems ossify are also different. There are two main types of ossification. Most
craniofacial bones of the axial skeleton undergo intramembranous ossification
(Gilbert, 2000). These dermal bones form directly from the mesenchyme, without a
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cartilage precursor. Conversely, the limb bones of the appendicular skeleton form
through endochondral ossification. Endochondral ossification occurs through the
formation of a cartilage template, which is eventually replaced by bone. During both
intramembranous and endochondral ossification epithelial and mesenchymal tissues
interact via inductive signalling events. Previous studies have largely focused on the
development of endochondral bones (specifically in the limb) (see review, Johnson
and Tabin, 1997). In comparison, far less is known regarding the development of
intramembranous bones. The study of calvariae has produced the majority of the
information regarding intramembranous bone development (Rice et al. 2003., Hornik
et al, 2004., Gross and Hanken, 2008). However, the developmental pathways for
other intramembranous bones, such as the scleral ossicles of the eye, remain
unknown.
1.2 Intramembranous vs. endochondral ossification
Intramembranous bones such as some calvariae and scleral ossicles, begin to form
when neural crest derived mesenchymal cells migrate to the craniofacial region and
interact with the epithelium, these interactions are known as an epithelial-
mesenchymal interactions. Once the epithelial-mesenchymal interactions occur, the
mesenchymal cells aggregate to form a skeletogenic condensation (Hall and Miyake,
2000). The condensation of mesenchymal cells requires a variety of conditions in
order to continue developing. The condensation must reach a specific size, must
upregulate tissue specific genes, and must obtain proper vascularisation (Hall and
Miyake, 2000). Once these specific conditions have been met within the
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condensation, the mesenchymal cells differentiate into osteoblasts (the matrix
secreting cells), and ultimately osteocytes. Osteocytes are the main cell type in a fully
developed bone. These cells are responsible for the maintenance of the bone, through
waste and nutrient exchange with the blood. Osteocytes form when osteoblasts are
surrounded by the osteoid matrix they have secreted (Reviewed in Franz-Odendaal et
al, 2006).
The development of endochondral bone begins in a similar fashion to
intramembranous bone, with epithelial-mesenchymal interactions resulting in a
mesenchymal condensation. The aggregation of mesenchymal cells will differentiate
into chondrocytes, the cells responsible for laying down a cartilage matrix. This forms
a template of the future bone that consists of only cartilage; at the center point ofthat
early-bone the chondrocytes will begin to undergo apoptosis and hypertrophy. As
these cells undergo apoptosis, space is created within the premature bone and the
vasculature penetrates. Once blood flow reaches the developing bone, nutrients,
oxygen and osteoprogenitor cells are brought to the location of osteogenesis. These
osteoblasts will then transform the cartilage matrix into osteoid matrix, ultimately
completing the development of the bone.
In both endochondral and intramembranous bone development cell-to-cell and
tissue-to-tissue signals are critical. The first signalling event is an epithelial-
mesenchymal interaction. Therefore, taking a closer look at the signals involved
during epithelial mesenchymal interactions could provide insights into the key factors
behind the inductive mechanisms that control the proper development of the skeleton.
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The primary goal of my thesis was to search for the developmental signals involved
in the induction and growth of specific intramembranous bones within the eye, the
scleral ossicles.
1.3 A description of scleral ossicles and their development
In vertebrates, the eye is a complex and crucial organ. In many species, including
mammals, most snakes, and many amphibians, the eye is void of any skeletal
structures (Franz-Odendaal and Vickaryous, 2006). The sclera, in mammals, is a dense
fibrous layer of connective tissue that is continuous with the cornea. Conversely, for
reptiles and teleost fish, skeletal tissues are found within the sclera. The sclera is
reinforced for support with scleral cartilage, scleral ossicles, or both. Scleral cartilage
can form in a variety of morphologies (from a narrow ring of cartilage to a full
cartilage cup). In many cases, the sclera also develops scleral ossicles. Scleral ossicles
are typically intramembranous bones, however in teleosts they develop through
perichondral ossification.
In reptiles, scleral ossicles hold a slightly different position in the eye from the
scleral cartilage. While the cartilage is continuous with the cornea, and forms around
the posterior part of the eye, the ossicles form at the anterior limit of the sclera (Franz-
Odendaal and Vickaryous, 2006). The number and morphology of scleral ossicles can
vary across different taxa. In general, each scleral ossicle will grow and overlap the
adjacent ossicle. This overlapping results in a ring, the sclerotic ring. Ossicles are
thought to be more important for accommodation in the eye, rather than structural
support. This is suggested since birds with the necessity for extreme eye
accommodation (such as diving birds) have very predominant ossicles. My research
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does not pertain to cartilage therefore the following information will focus on scleral
ossicles, more specifically scleral ossicles in the chicken.
In the chicken, scleral ossicles are intramembranous bones that develop through
interactions with conjuctival papillae, which are small clusters of epithelial cells
(Coulombre and Coulombre, 1962). Despite the fact that these papillae form from the
conjunctival epithelium, they are commonly referred to as 'scleral' papillae
(Hamburger and Hamilton, 1951) and will be referred to as such in this thesis. These
papillae can be found in direct correlation (1:1 ratio) with the number and pattern of
scleral ossicles that will form (Figure 1). There is a unique sequence by which the
scleral ossicles develop (first investigated and described by Coulombre and
Coulombre, 1962). More recently this pattern was described in Gallus gallus the strain
of chicken used in my research (Franz-Odendaal, 2008). In Gallus gallus the number
of papillae present can range from 13-16 per eye. First a small group of papillae (3-4)
will form over the ciliary artery, followed by another group of papillae directly across
from the first group. Temporal then nasal groups of papillae form until there is a
complete ring (Figure 2). The number of papillae (and therefore scleral ossicles) is
often asymmetric from right to left eye in the same embryo. 50% of embryos might
have asymmetry in papillae and ossicle number; however there is rarely a difference of
more than one papilla/ossicle between the right and left eye (Franz-Odendaal, 2008).
The range and asymmetry of the numbers of scleral papillae make a classical
numbering system challenging (Figure 2).
It has been demonstrated that Scleral ossicle induction occurs after papillae
formation (Figure 3). This induction occurs in the same sequence as the development
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of scleral papillae. After induction, the mesenchymal cells underneath the papillae
aggregate forming a condensation and the papillae degenerate. These mesenchymal
condensations will then differentiation into osteoblasts, which lay down osteoid
matrix. As the ossicles grow, they eventually overlap giving rise to the sclerotic ring
(Figure 3).
Early studies suggest that the induction of scleral ossicles occurs during HH
stages 30 to 36 (Pinto and Hall, 1991). This study also demonstrated that the induction
signal occurs by a diffusible factor from the epithelium. In a later study, it was
demonstrated that sonic hedgehog is present in the papillae during HH stage 35 and 36
and may be a potential inductive signal from the epithelium (Franz-Odendaal, 2008). It
is therefore suggested that the stages when induction is likely occurring are HH 35 and
36. Therefore, it is understood that an epithelial mesenchymal signalling event is
important for the induction of scleral ossicles, similar to other intramembranous bones.
It is also suggested that the signalling factor during induction is diffusible. However,
very little is known about exactly what genes and signalling molecules are involved in
the developmental pathway of scleral ossicles.
One of the most recent studies involving scleral ossicles in chick embryos
investigated one developmental gene family, the Hedgehog family (Franz-Odendaal,
2008). Through implantation of affi-gel beads soaked in cyclopamine (a Hedgehog
family inhibitor) it was demonstrated that the Hedgehog family of genes is crucial to
the induction of scleral ossicles. When exogenous cyclopamine was placed next to a
papilla during induction, the formation of the underlying ossicle was inhibited. This
suggests a role for the Hedgehog family in the induction of scleral ossicles at HH stage
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35 and 36. However other members of the Hedgehog family could not be ruled out,
since cyclopamine inhibits the entire Hedgehog family including indian hedgehog and
desert hedgehog (Pathi et al, 1999). Desert hedgehog is involved with sexual
development and has never been implicated in bone or cartilage development in any
vertebrate. Indian hedgehog has been shown to be involved in bone development (for
example during endochondral ossification in the limb) and therefore it could
potentially be involved in the induction of scleral ossicles. Determining whether or not
indian hedgehog is involved, as well as, what role sonic hedgehog is playing during















Figure 1: Diagrammatic representation of a cross-section through a single scleral papilla





Figure 2: Schematic representation of the patterning of scleral papillae development in
chicken. Numbers on the scleral papillae indicate conventional numbering of scleral
papillae with 1 on the choroid fissure and 12 on the ciliary artery (Fyfe, 1980). Brackets
indicate the sequence in which the papillae develop. The first papilla develops on the
ciliary artery and then a couple more form adjacent to the first. Then, directly across from
the first group, the second groups will form. Following that, a temporal group of papillae




Stage HH 30 (6.5-7 days): first papillae present over the
ciliary artery
Stage HH 34 (8 days): full ring of scleral papillae is present
Stage HH 35 (8.5-9 days): Scleral papillae begin to induce
the underlying mesenchyme
Stage HH 36 (10 days): Induction ends, papillae begin to
degenerate
Stage HH 37 (11 days): Mesenchymal condensation
formation begins (dense aggregation of cells seen in
unstained embryos)
Stage HH 38 (12 days): Mesenchyme differentiates forming
osteoblasts that lay down bone matrix to form ossicles
(condensations are distinct)
Stage HH 40 (14 days): Ossicles begin to overlap
Post hatching (post 21 days): Ossicles have ossified and fully
overlapped to form the sclerotic ring
Figure 3: Timeline for the development of scleral ossicles modified from Franz-
Odendaal (2008). Timeline shows Hamburger and Hamilton (1951) stages as well as
embryonic days.
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1.4 Potential developmental pathways involved in scleral ossicle induction
Apart from shh, there has been no demonstration of gene involvement during the
induction of scleral ossicles (Franz-Odendaal, 2008). It was shown via real-time PCR
that there is a slight increase in expression ofboth tenascin C and bone morphogenetic
protein 4 during the induction stages (HH 35 and 36) of scleral ossicle development.
However, whether or not these genes play a critical role in the development of scleral
ossicles is still unknown. Based on the involvement of several different genes during
the induction of other bones (such as the calvariae, the dentary, and the limb bones) a
number of candidate genes potentially exist.
1.4.1 Hedgehog family
Shh mRNA was found in the papillae during the induction of scleral ossicles,
however it is unknown where the protein for that gene will be received since shh is
able to signal at both long and short ranges (Drossopoulou et al, 2000). The location
of the receptor for shh would give further insight into the role shh plays during the
induction of scleral ossicles. Patched (ptc) is a transmembrane receptor that is
associated with a G-protein coupled transmembrane receptor molecule smoothened
(smo) (Carpenter, et. al, 1998). Ptc is the ligand receptor for the entire Hedgehog
family of genes. Ptc normally inhibits the function ofsmo in the absence of any
hedgehog signal. However, when a hedgehog protein binds to the ligand receptorptc,
smo is no longer inhibited and a transmembrane transduction reaction occurs
activating the downstream hedgehog target. In order to determine which cells and
tissues are receiving the shh signal, the location and distribution of its receptor (ptc) is
often used (Traiffort et al, 1998., Harfe et al, 2004).
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As previously stated a prior study used cyclopamine to inhibit the entire
Hedgehog family of genes and thereby preventing the formation of a scleral ossicle
(Franz-Odendaal, 2008). Since cyclopamine inhibits the entire Hedgehog family, not
just shh alone, it is unknown whether or not shh works in cooperation with another
vertebrate Hedgehog gene such as Indian hedgehog (ihh). Indian hedgehog is
important during endochondral ossification in the appendicular skeleton. Ihh activates
runx2 which induces the differentiation of chondroblasts to osteoblasts (Yang, 2009).
There is no evidence that ihh is involved during intramembranous bone development.
It has been suggested that ihh regulates runx2 during endochondral bone development,
however during intramembranous bone development shh plays the role of activating
runx2 and subsequently initiating osteoblast differentiation (Yang, 2009). Therefore
previous studies suggest that shh is likely the only Hedgehog gene playing a role in
this intramembranous ossification pathway, however ihh can not been ruled out as a
possible factor in the induction of scleral ossicles.
1.4.2 The bone morphogenetic protein family
The bone morphogenetic protein (BMP) family of genes is part of a much larger
family of proteins known as the transforming growth factor beta super family (TGFßs)
(Dudley and Robertson, 1997). All of these proteins are secreted proteins. Originally it
was thought that there were only seven members of the BMP family, but today there
are twenty recognized BMPs (Feely et al, 2005). Studies indicate that many BMPs
are involved in specific aspects of bone growth and development. BMP involvement
includes; recruitment of mesenchymal cells into early bone condensations (Hall and
Miyake, 2000), ensuring that neural crest derived mesenchymal cells are committed to
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become osteogenic (or chondrogenic) (Abzhanov et al. , 2007), and the regulation (in
correlation with msx andfgfgenes) of differentiated and undifferentiated cells during
the growth of osteogenic fronts in calvariae development (Kim et al, 1998). BMPs
are also produced as secreted signalling proteins during epithelial-mesenchymal
interactions, for example during tooth development. BMP!, 4, and 7 signals are
produced by the epithelium and induce the underlying mesenchyme as well as the
epithelium itself to gain competence for further inductive events (Thesleff, 2003). The
BMP family of genes is involved in a wide variety of inductive events during bone
development and are therefore excellent candidates for involvement in the
development of scleral ossicles. Since there are so many different possibilities for
which precise member of the BMP family is involved in this developmental pathway,
the most efficient way to investigate BMP involvement is through inhibition of the
entire family of genes.
The bone morphogenetic protein family of genes has two common inhibitors,
noggin and gremlin. Noggin is a secreted protein found in developmental pathways
which inhibit the BMPs by binding to the protein and rendering it inactive
(Zimmerman et al, 1996). Noggin has increased affinity for BMP2, BMP4, and
BMP7. Gremlin is also a secreted protein that works as an antagonist to the bone
morphogenetic protein family (Hsu et al, 1999). Gremlin acts in a similar fashion to
noggin by binding to the secreted BMP proteins rendering them inactive. Gremlin is
suggested to have the same increased affinity for BMPs 2, 4, and 7. Despite having
very little gene sequence in common, it is thought that gremlin and noggin likely share
structural similarities that allow them both to bind specifically to BMPs. Although,
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noggin and gremlin are effective inhibitors ofBMP2, 4, and 7, noggin is most
commonly used for implanting the protein on beads in vivo (Chang et al, 1999,
Botchkarev et al, 2001, Chung et al, 2007, Hosoya et al, 2008/
1.4.3 Other candidate genes
The msx family of genes are homeobox genes that are homologous to Drosophila
muscle segment homeobox gene (msh). In vertebrates, this gene family consists of
three members (msxl, msx2, msx3), however only msxl and msx2 are found widely
expressed throughout development, particularly where epithelial mesenchymal
interactions occur (Alappat et al, 2003). In addition, Msxl and msx2 have previously
been reported to be involved during the development of the facial skeleton, in the
developing dentary as well as in the sutures and developing condensations of the
calvariae. Specifically, Msx2 is found in the suture mesenchyme and dura mater of the
developing calvariae. In wild-type mice, msx2 is required to maintain the proliferation
of osteoblasts at the osteogenic fronts of the developing calvariae (Liu et al, 1999). If
msx2 expression is increased, the population of osteoblasts present at the osteogenic
front undergoes considerable growth. However, if msx2 is inhibited then
differentiation occurs prematurely resulting in craniosynostosis (the premature closure
of the sutures in the skull) (Dodig, et al, 1999). It has been suggested that msx2 has a
regulatory function controlling the balance between proliferation and differentiation of
osteoblasts during calvariae development due to its downstream activation of runx2
(Rice et al, 2003). For this reason, it could be hypothesized that msx2 might also play
a role in the expansion and growth of scleral ossicles in the chicken eye as they start to
overlap to form the sclerotic ring.
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Msxl expression is found to have a very similar pattern to msx2 in a variety of
prenatal tissue interaction sites in the craniofacial region such as, the developing
calvariae, distal regions of the facial primordial, and the teeth (Alappat et al, 2003).
The large difference in expression between msxl and msx2 is demonstrated after birth.
Msxl continues to be expressed after birth in the late stages of skull morphogenesis
while there is a sharp decline in the expression of msx2. Therefore when investigating
the msx family of genes, msx2 is more specific to pre-natal development and is
therefore of more interest than msxl when working with embryos.
Scleraxis is a member of the basic helix-loop-helix (bHLH) family of
transcription factors. This family of transcription factors has been shown to play an
important role in developmental processes such as cell differentiation and
proliferation. Scleraxis is typically found in the area of chondrogenesis that precludes
the development of endochondral bones such as the limb and hyoid bones (Cserjesi et
al, 1995). Scleraxis is also common in other connective tissue areas such as; tendons
and ligaments, chest wall, diaphragm, tongue, and heart valves. Although scleraxis is
not found in the developing calvarial bones or any other intramembranous bone, it has
been found in the mesenchymal cells of the frontonasal region (Brown et al, 1999).
Despite no published account of the presence ofscleraxis during intramembranous
bone development, we were informed of its potential presence in scleral papillae
(personal communication, J. Richman, UBC).
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1.5 Objectives
The broad objectives of this study are to gain further knowledge and
understanding about the development of scleral ossicles and intramembranous bones,
in general.
The specific objectives are:
1 . Determine if the bone morphogenetic protein family of genes is involved in the
development of scleral ossicles.
2. Determine if indian hedgehog is present during scleral ossicle induction.
3 . Determine the location and distribution of the Hedgehog ligand receptor, patched.
4. Determine if msx2 and scleraxis are present during scleral ossicle development.
These objectives were investigated through in situ hybridization and affi-gel bead
implantation in the chicken embryo.
2.0 Materials and Methods
2.1 Chicken embryos
Fertilized chicken eggs of the strain Gallus gallus were obtained from Cox Bros.
Farm in Truro, Nova Scotia. Eggs were kept at 4 0C degrees for no more than one
week before being incubated at 370C with approximately 40% humidity. Eggs were
turned once daily.
2.2 Staging chicken embryos
Chicken embryos were staged using the Hamburger and Hamilton (1951) staging
chart. Embryos were staged at two different time points. First, embryos were staged
before ex-ovo culturing. The ideal stage for ex-ovo culturing was HH stage 19 (3-3.5
days of incubation). HH stage 19 was characterized by the following morphological
traits. Somites had extended into the majority of tail (37 -40), however the end of the
tail remains unsegmented. This extension of the somites distinguishes a HH stage 19
embryo from a HH stage 1 8 embryo since at HH 1 8 the somites are not as far into the
tail (30-36). Also, the tail bud remains curled. The allantois is still quite small, and has
no vasculature. The main difference between HH 19 and HH 20 is that at HH stage 19
the eyes have no pigment while at HH stage 20 a greyish hue is visible.
Embryos are staged again before bead implantation surgery to ensure that the
embryos are at HH stage 35 (8.5-9 days incubation), and have not yet reached HH
stage 36 (10 days incubation). This stage is crucial because bead implantation needs to
occur at the beginning of induction (HH 35). The main characteristic that was used to
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distinguish between these two stages was the nictitating membrane. If the nictitating
membrane was completely covering any of the papillae, the embryo was considered
too old for bead implantation because at HH stage 36 the nictitating membrane begins
to cover the most anterior papillae. In order to ensure the embryos were not too young,
HH stage 34 embryos were recognized by the nictitating membrane being halfway
between the outer rim of the eye and the scleral papillae. This membrane was much
closer to the scleral papillae by HH stage 35. Also, at HH 34 the distance between the
tip of the beak and the eye was smaller than at HH 35 due to the lengthening of the
visceral arches at HH 35. These characteristics ensured that the embryo was at HH
stage 35 when bead implantation occurred.
2.3 Microsurgery
2.3.1 Tools
Fine needles were made for the bead implantation surgery. Glass pipettes were
pulled over a flame and using a diamond glass cutter the pipette was etched until a
clean break was made, leaving one end with a very fine hole. Fine (0.1 mm) and
coarse (0.25 mm) tungsten wire (Alfa Aesar, H08S018 and C12N03) was cut
approximately two centimetres in length and was carefully threaded into the tip of the
pulled pipette. The glass tip and wire were then briefly placed back over the flame,
causing the glass to melt, sealing the wire in place. The needles were sharpened using
electric current as follows. First, a IN NaOH solution was placed into a plastic beaker.
Then a straightened paperclip was placed over the edge of the beaker, partially
submerged in the NaOH solution. One wire was plugged into an AC power source and
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connected to the paperclip. Another wire was also plugged into the power source,
leaving the other end free. The power source was turned on and both the needle and
the free end of the wire were partially submerged in the NaOH. The electrolytic
properties of the solution and the paperclip will cause a sharpening at the tip of the
needle.
Affi-gel beads (BioRad 153-7302) were used for all experiments. Noggin-soaked
beads were prepared by first choosing approximately 30 beads of similar size from a
stock of beads, which are stored in PBS at 40C. These beads were placed into a 0.1 ml
sterile eppendorf tube and spun at 13000 RPM for five minutes in a centrifuge in order
to remove all of the PBS. The beads were then placed at room temperature for an hour
to ensure full dehydration (noted by shrivelled beads). Following this, 1 µ? of
recombinant mouse noggin (reconstitute as 25 µg of noggin in 25 µ? of DepC treated
IX PBS, to give a final 1µ§/µ1 concentration) (R&D Systems, 1967-NG) was placed in
the tube with the beads. The beads were then left to incubate at room temperature for
one hour to allow the beads to absorb the noggin. Following the one hour, the tube was
placed on ice until bead implantation was complete. This allowed for all 30 beads of
approximately the same size to absorb the same quantity of the 1.0µ§/µ1 noggin
solution. Control beads were rinsed 20 times in DepC treated IX PBS.
2.3.2 Shell-less culturing (ex-ovo)
Ex ovo culturing was performed instead of windowing the eggs due to the
restricted access to the embryo through windowing. Easy access to a specific papilla at
HH stage 35 was required. At HH stage 35, in a windowed embryo, the head of the
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embryo could be partially or completely inaccessible making the surgery impossible.
Also, the small hole in the egg present when using a windowed embryo makes it
challenging to use forceps and fine needles. Due to the limitations of the windowing
method, embryos were prepared for ex ovo culturing at HH stage 19 as follows.
Before removing the embryo, the shells were sprayed with 70% ethanol and
allowed to dry. Using a mortar and pestle, an empty shell was crushed into a fine
powder and the shell was placed at the bottom of a weigh boat (Fischer Scientific,
087321 13, 88 ? 88 ? 23 mm). The egg was carefully cracked and the embryo was
placed directly into a sterile weigh boat. The embryo was inspected to ensure that the
yolk was still perfectly intact (Figure 4A). If the yolk had broken, the embryo was
discarded as it will not survive ex ovo. The embryo was also observed to ensure that it
was viable; the heart was beating, vasculature appeared normal, and no obvious
abnormalities were present. Using a pipette 40 µ? of penicillin/streptomycin (5,000 U
Penicillin: 5 mg Streptomycin, Sigma P4458) was placed over the surrounding
albumin of the embryo to help fight infection. A humidity chamber was also prepared
(Figure 4B and C) for each embryo as follows: a small stack of Kim-wipes and an
absorbent pad made of cotton were placed in the bottom of a Tupperware container
(12 cm ? 12 cm ? 6 cm). Distilled water was added to moisten the Kim-wipes and
cotton (approximately 200 ml of water). The embryo was then placed in its weigh boat
on top of the moist padding and half of a square sterile petri-dish (9.5 cm ? 9.5 cm)
was placed overtop to form a loose lid for the weigh boat. The Tupperware container
was then covered with its lid. Two corners of the lid were sealed ensuring a partial seal
that still allowed for good air flow inside of the chamber. The embryo was then
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carefully placed back into a 370C incubator until desired stage for bead implantation.
Containers of water were placed in the incubator to help control humidity. All water in
the humidity chambers and in the incubator was replenished as needed during the
incubation period.
Many different techniques were attempted in order to optimize the ex-ovo
culturing. Different absorbent padding, different antibiotic doses, different entry points
through the membranes, as well as increased sterile techniques were all tried in order
to increase the survival rates of the embryos ex ovo. Despite these efforts, embryos
survived well up until HH stage 37 at which point a large die off would consistently
occur.
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Figure 4: The ex ovo culturing technique. (A) A HH stage 25 embryo after removal
from the shell, arrow points to embryo with vasculature and yolk that are not broken.
(B) A HH stage 40 embryo in an open humidity chamber (C) The complete humidity













Tungsten needles and fine forceps were disinfected with 100% EtOH, and then
flamed before surgery. An ex ovo cultured embryo at HH stage 35 (10 days of
incubation) was removed from the incubator and placed under a Nikon (SMZlOOO)
dissecting microscope. Using forceps, a small hole was torn in the membranes
surrounding the embryo. The placement of this hole was typically in an area free of
major blood vessels and directly over the eye (Figure 5). Once access to the eye had
been gained, a fine tungsten needle was used to make a small hole in the conjunctival
epithelium of the eye directly next to a scleral papilla. If access was ideal, the bead
was placed next to scleral papilla 8 or 9 (Figure 2). Using fine forceps a prepared affi-
gel bead was placed on the torn membranes, near the opening to the embryo. Using a
tungsten needle the bead was moved over to the epithelium of the eye and gently
pushed directly underneath the conjunctiva. A 45 µ? dose of penicillin/streptomycin
(5,000 U Penicillin: 5 mg Streptomycin, Sigma P4458) was again placed on the
albumin of the embryo to prevent infections. The petri-dish and Tupperware lids were
placed back over the embryo and the embryo was placed back in the 370C incubator.
Embryos continued to develop until HH stages 39-41 (13-15 days of incubation). The
embryo was then decapitated and the head was fixed in 10% Neutral Buffered
Formalin (Fischer Scientific - 245685) overnight at room temperature followed by
processing through a graded EtOH series. In total, 153 noggin-soaked beads and 172
IX PBS-soaked beads were implanted into individual eyes (1 per embryo) adjacent to






Figure 5: Bead implantation surgery. (A) Embryo HH stage 35 exposed through a
small hole torn in the overlying membranes in order to gain access to the underlying
eye for bead implantation. (B) High magnification of the affi-gel bead adjacent to a
scleral papilla. Scale bar in A is 100 µp?.
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2.3.4 Alkaline phosphatase stain to visualize ossicle formation
The alkaline phosphatase stain protocol was followed according to Edsall and
Franz-Odendaal (2010). Previously fixed specimens were rehydrated through a graded
EtOH series to 100% distilled water, followed by three 15 minute washes in distilled
water. The specimens are then incubated in tris-maleate buffer pH 8.3 (0.605 g
trizma base, 0.55 g maleic acid, 25 ml distilled water) for one hour at room
temperature. All of the following steps occurred in the dark. Embryos were incubated
in alkaline phosphatase substrate solution (0.1 ml of 10mg/ml napthol-AS-TR-
phosphate (Sigma - N6125) in N, N-dimethylformamide (Sigma - D4551), 8 mg
diazonium salt (Sigma -D9805), 10 ml tris-maleate buffer pH 8.3) for one hour at
room temperature. To stop the enzyme reaction, the samples were washed three times
for 1 5 minutes in saturated sodium borate water. Embryos are then bleached (to
remove eye pigment) in 10% hydrogen peroxide made with 1% KOH overnight.
Finally embryos were processed through a graded glycerol series and stored in 80%
glycerol. The alkaline phosphatase stain was performed with embryos at HH stage 38
and older. HH stage 37 embryos were too young; the condensation formation has
started but the differentiation of the osteoblasts is not complete (Figure 3).
2.4 Probe preparation and whole-mount in situ hybridizations
2.4.1 Amplification of plasmids containing cDNA
Plasmids containing Indian hedgehog etna patched cDNA were obtained from
Dr. John Fallon (Department of Anatomy, University of Wisconsin Medical School)
and plasmids containing MSX2 and scleraxis cDNA were obtained from Dr. Joy
25
Richman (Department of Oral Health Sciences, University of British Columbia).
Plasmids were removed from the filter paper by adding 100 µ? of TE buffer (1OmM
tris-HCl, 0.1 M NaCl, pH 8.0). After five minutes, the sample was mixed using a
vortex and then spun at room temperature for one minute at 3000 RPM. The tube was
then incubated at room temperature for 30 minutes and the filter paper was carefully
removed from the solution. The solution with the plasmid was stored at -20 0C until
required.
Plasmids were transformed into Escherichia coli bacteria competent cells
(HBlOl Competent cells, Promega LlOl 1). Polypropylene culture tubes and sterile
tips were chilled in a -2O0C fridge before use. Competent cells were removed from the
-8O0C freezer and placed on ice to thaw. Using a chilled pipette tip, competent cells
were gently mixed and 100 µ? was placed in a chilled 5 ml tube. 10 µ? of the plasmid
solution was added to the competent cells. The solution was chilled on ice for 20
minutes, heat shocked for 50 seconds in a 420C water bath, and then placed back on
ice for two minutes. Then, 900 µ? of cold 2.5% Luria-Bertani (LB) broth (Difco,
244320) was added to the competent cells/plasmid mixture. This mixture was
incubated for one hour at 37°C with vigorous shaking. During this time 0.01%
ampicillin in 2.5% LB agar plates (Appendix A) were warmed upside-down in a 370C
incubator. Finally, 100 µ?, 10 µ?, and 1 µ? volumes of the LB broth with the competent
cells mixture were placed on each plate and a flamed loop was used to distribute the
cells evenly. The plates were incubated overnight at 37 0C.
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The following day transformed E. coli were amplified. Using a sterile pipette
tip a single colony was placed into a 10 ml RNAse free falcon tube containing 4 ml of
LB broth. The tube was then sealed and incubated at 370C with vigorous shaking,
overnight.
2.4.2 Isolation of plasmid
In order to isolate the plasmid containing cDNAs, a mini preparation protocol
was performed. The E. coli cells were lysed and the plasmid was removed (Appendix
B). To verify the concentration of the plasmid obtained from the mini preparation
protocol, the UV absorbance at 260 nm and 280 nm was recorded using a
spectrophotometer (Thermo scientific, Genesys \0uv). The spectrophotometer reading
was taken using 4 µ? of plasmid sample in 1 16 µ? of distilled water, a dilution of 29
times. A 260 nm reading was used to determine the concentration of the sample and
the 260 nm/280 nm ratio was used to determine the purity of the sample (Table 1). A
ratio of approximately 1.8-2.2 was considered acceptable. The concentration of the
samples was determined using the formula: [DNA] = (50ng^l/absorbance unit ?
Dilution Factor ? OD260)/1000.
Table 1: Spectrophotometer results for the plasmid containing patched cDNA
Gene OD260 OD280 Purity Concentration




2.4.3 Linearization of plasmids
The plasmids were linearized using predetermined restriction enzyme cut sites
within the designed plasmid. The linearization procedure was typically done with a
total volume of 100 µ?, except in specific cases when it was possible to do the
digestion with a total volume of 20 µ?. To stop the linearization reaction, heat
inactivation was performed by placing the tubes in a 650C water bath for 1 5 minutes.
Samples were stored at -2O0C.
Table 2: Reaction conditions for linearization of amplified plasmids containing cDNA



































































2.4.4 cDNA purification and gel electrophoresis
A high pure PCR product purification kit was used to clean up the linearized
Plasmids (Roche, 14056400). After plasmids had been purified, two elutions were
collected for each sample. 2 µ? (at least 1 µg of DNA) of each elution were loaded onto
a 1.5% agarose gel in IX TBE (5X stock -27 g Trisma buffer, 13.75 g of boric acid,
0.372 g of EDTA, in 500 ml dH20), with 0.05% ethidium bromide (Sigma, E1510). A
one kilobase ladder (Promega) was also loaded onto the gel. Gel electrophoresis was
performed at 1 10 volts for approximately 45 minutes. DNA bands were observed to
ensure samples had been appropriately linearized and purified.
2.4.5 Synthesizing the RNA probe
The RNA probe was made using a Digoxigenin RNA labelling kit (Roche
1 1401420) (Appendix C). ^g of each DNA sample was used to create a labelled RNA
probe. Specific polymerases (T3 or T7) were required depending on the site of
restriction enzyme digestion that occurred during the linearization step (Table 2). To
stop this reaction, 2 µ? of 0.2M EDTA was added to each tube. Probe was stored at
-2O0C until ready to use.
In order to verify that the probe had been labelled correctly, five dilutions were
made (1 ng/µ?, 10 pg/µ?, 3 pg/µ?, 1 pg/µ?, and 0.3 pg/µ?) as suggested by the
digoxigenin high prime RNA labelling protocol (Appendix D). Briefly, the detection
protocol involves placing 1 µ? of each dilution and 1 µ? of a pre-labelled RNA probe
from the kit (positive control) onto a nylon membrane (Roche, 571 12314). The
membrane is baked at 12O0C to ensure that the probe is not washed off the membrane
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during the protocol. The membrane is then washed in Maleie acid buffer (0.1 M
Maleic acid and 0.15 M NaCl) and placed in a blocking solution (2% Sheep serum,
3% skim milk powder, IX TBST). After blocking, a quick IX TBST rinse is done and
the membrane is placed in an antibody solution (1:5000 anti-digoxigenin-AP in IX
TBST). The membrane is then placed in washing buffer (0.1 M Maleic acid, 0.1 5M
NaCl, 0.3% Tween) and equilibrated before placing in detection buffer (0.1 M Tris-
HCl and 0.1M NaCl). The membrane is incubated at room temperature in the detection
solution, and viewed every five minutes. The colour reaction takes anywhere from half
an hour to 12 hours. The colour of each dilution can be analyzed to determine the
approximate concentration of the probe from the kit. If the intensity and colour of each
sample is similar to the intensity and colour of the probe from the kit then this




Dilution 1 Dilution 2
Figure 6: Dot blot results for the indian hedgehog and msx2 probes. Dots for ihh and
msx2 are similar in colour and intensity to the control dots, which indicate efficiently
labelled synthesized probes. Only the first two dilutions at 1 ng/µ? and 10 pg/µ? are
shown.
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2.4.6 Whole-mount in situ hybridization
Whole-mount in situ hybridization protocol was adapted from Nieto et al. (1996)
(Full detailed protocol is given in Appendix E). Briefly, embryos were staged using
the Hamburger and Hamilton (HH) staging chart. HH stages 30 through 40 were
collected and fixed in 4% Paraformaldehyde (Sigma, P6148) in PBST, overnight at
40C. The following day, heads were processed through a graded methanol series to
100% methanol and left to de-hydrate for at least one hour. After dehydration heads
were bisected. Half-heads were then rehydrated and bleached to remove eye pigment.
The half heads were stored at -2O0C in IX hybridization solution (0.005% yeast tRNA
and heparin in prehybridization solution). Embryos were then permeabilized using a
50 µg/ml Proteinase K solution, and post fixed in a 1:1 solution of 4% PFA in
IXPBST: 0.25% Gluteraldehyde (in IXPBST). The half heads were hybridized in
probe overnight at 600C with shaking. The following day, the embryos were washed
and placed in a blocking solution (20% heat inactivated sheep serum in IX TBST).
After the antibody is pre-absorbed (in chick powder), the embryos are placed in the
antibody solution (1:10,000 anti-digoxigenin-AP antibody (Roche - 12930020) in
blocking solution) overnight at 40C with shaking.
To reduce background signal, the embryos were washed in a 2 mM levamisole
solution. Embryos were then placed in colour detection for 24 to 36 hours in the dark.
The colour reaction was stopped with 5 mM EDTA in IX PBST. The embryos were
fixed in 4% PFA, and dehydrated through a MeOH series. Once in 90% MeOH, they
were left overnight in order to leach the background signal from the embryos. Finally,
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the embryos are placed in a 1 : 1 solution of glycerol: distilled water and stored in the
dark at 40C.
This protocol was performed with two controls. One control was an embryo that
would receive sense probe instead of the normal antisense probe. This was to ensure
that the addition of a non-specific probe, did not give the same expression pattern as
the antisense probe that binds specifically to the gene of interest. The other control
was an embryo that would receive no probe. This was to ensure that the other steps in
the protocol were not creating the expression pattern shown by the antisense probe
experiments. This entire protocol was performed at least three times for each gene
that was investigated.
2.4.7 Optimizing the whole-mount in situ hybridization protocol
In order to determine which candidate genes are involved in the development of
scleral ossicles, in situ hybridizations were performed. To ensure that the whole-mount
in situ hybridization protocol was working correctly, shh probe was used. Shh
expression was found in the developing feather bud starting at HH stage 35 (Harris et
al., 2002, Franz-Odendaal, 2008). Once the protocol was optimized, the other
candidate genes were investigated.
For each new gene (ihh, msx2, scleraxis, and ptc), the initial embryo stages that
were investigated using in situ hybridization were HH stages 33, 35/36, and 38. These
stages were chosen in order to test a stage before induction (HH 33), during induction
(HH 35 or 36), and after induction when condensations are present (HH 38) (Figure 2).
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If the gene was detected in any of these stages, then subsequent in situ hybridizations
were performed including all the stages between HH 30 and HH 40.
2.4.8 Sectioning whole-mount in situ hybridization samples
Tissue was dissected from the eyes that had undergone in situ hybridization.
These tissue samples were sectioned using a microtome or a cryostat, in order to
determine the cellular location of the in situ hybridization signal.
Microtome sectioning: Tissue samples were dehydrated through a graded EtOH series
to 100% alcohol. The tissue was placed in Citrosolve (Fischer Scientific, 22-143975)
overnight. The tissue samples were then placed in molten paraffin wax (Fischer
Scientific, 8889-502004) and the wax was changed twice. After 12 hours, the samples
were embedded in wax and placed at -2O0C overnight. The tissue was serially
sectioned at 5 µp? and the sections were left to set on the slides overnight at 37 0C. The
following day, the slides were de-waxed through a series of Citrosolve rinses and
coversliped. Finally the slides were examined under the compound microscope (Nikon
Eclipse 50/).
Cryostat sectioning: Tissue samples were hydrated to 100% distilled water. A 1% agar
solution was heated until the agar dissolved. The liquid agar solution was poured into
a small petri dish and after one minute of cooling, the tissue sample was place into the
agar liquid. The agar then hardened and was cut into a small block. The block of agar
containing the tissue sample was placed in a 30% sucrose solution overnight, at room
temperature. The sucrose solution was then drained and the block was placed in the
tissue freezing medium (Jung - 020108926) onto the chuck. The agar block was
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frozen onto the chuck in the cryostat for 10 minutes. Sections were cut at 5-10 µ?? and
placed on slides. Slides were stored in the -2O0C freezer. The slides were conversliped
and viewed under the compound microscope (Nikon Eclipse 50z).
2.5 Photography and image analysis
Both the compound (Nikon Eclipse 500 and the dissecting (Nikon SMZlOOO)
microscopes are camera capable (Nikon digital camera DXM 1200C). In order to
capture the digital photos the camera was connected to a computer and the program
Nikon NIS-element (BR 3.0) software was used. This program was used to add scale
bars to all photographs. Also, the surface area measurements were performed using
this software. Once the pictures had been captured, cropping and contrast optimization
were performed in Corel Draw X3 (version 13.0).
34
3.0 Results
3.1 Inhibition of BMPs using affi-gel beads soaked in noggin
3.1.1 Results of PBS vs. noggin-soaked bead implantation
In order to determine if bone morphogenetic proteins (BMPs) are involved in the
development of scleral ossicles, affi-gel beads soaked in noggin, a BMP inhibitor, were
implanted into the eye adjacent to a scleral papilla. At HH stage 35 (Day 8.5-9, the onset
of induction), the bead implantation was performed. At HH stage 36, when induction is
thought to be occurring the noggin-soaked bead had no effect on the maintenance of the
adjacent papilla. The papilla next to the noggin bead maintains its normal developmental
pattern despite the inhibition ?? BMP in the surrounding tissues (Figure 7A&B). At HH
stage 40 (when condensations are present) the condensation that would form directly
beneath the papilla adjacent to the noggin-soaked bead was missing (Figure 7C&D). The
other condensations in the ring that were present during this time were very difficult to
view under the microscope and with the camera. Since these condensations are
translucent and often in the early stages of development, interpreting whether or not
ossicles had been affected was very challenging (Figure 7C &D). This problem was
overcome by using an alkaline phosphatase stain to mark the preosteoblasts and
osteoblasts present in the ossicle condensations (section 3.1.3). Bead implantation at HH
stage 35 was also performed with control affi-gel beads that had only been soaked in
PBS. 24 hours later, at HH stage 36, the implantation of PBS- soaked beads had no effect
on the adjacent developing papilla. This result also occurred in the noggin-soaked bead
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experiments. Conversely, these control beads had no effect on the development of the
underlying scleral ossicle in comparison to the noggin bead implantation (Figure 7E&F).
3.1.2 Embryo survival rates after microsurgery
The survival rates for the ex-ovo culturing, and therefore the bead implantation,
were low. Most of the embryos would survive 24 hours post surgery (HH stage 36).
120/153 individuals that had a noggin bead implanted in the eye survived 24 hours past
the surgery. Approximately the same percentage (-80%) of the individuals that had a
PBS-soaked bead implanted in the eye survived 24 hours past surgery (Table 3). The
critical stage in the shell-less cultured embryos was HH stage 37 (1 1 days). At this stage
the majority of the embryos would die. Approximately 95% of all the embryos that
underwent surgery (PBS- or noggin-soaked bead implantation) did not survive past HH
stage 37 (Table 3). Embryos that underwent noggin bead implantation and survived past
HH 37 (6/120) demonstrated that the ring of condensations was affected by this bead
implantation. All six of the embryos that survived the noggin bead implantation
demonstrated this result. Finally, embryos that had a control bead implanted and survived
past HH stage 37 (1 1/137) did not have any altered condensations in the eye.
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Table 3: Survival rates for ex-ovo embryos that underwent microsurgery. # indicates
number.
# of surgeries































Figure 7: Inhibition of BMPs by noggin results in the inhibition of ossicle formation. (A)
HH 36 embryo with noggin bead implantation (white arrowhead), all papillae are present
despite noggin exposure for the past 24 hours (bead implantation was performed at HH
35). (B) Magnified view of the insert from (A); noggin-soaked affi-gel bead and adjacent
papillae. (C) HH stage 40 after noggin bead implantation (white arrowhead)
demonstrating a missing condensation. (D) Diagrammatic representation of 13
condensations from (C), an asterisk depicts the original placement of the noggin bead. (E)
HH stage 40 embryo with a control PBS-soaked bead (white arrowhead) (F)
Diagrammatic representation of 14 condensations from (E), an asterisk depicts the
placement of the bead. Scale bar in A is 500µ??, B is 250µp?, and C&E are 500µ??.
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3.1.3 Further interpretation of the noggin bead implantations
Embryos that survived until HH stage 38 through 40 when condensation formation was
occurring were difficult to interpret. In order to view the condensations after bead
implantation more clearly, an alkaline phosphatase stain adapted from Edsall and Franz-
Odendaal (in press) was used. This stain works through an enzymatic reaction that occurs
with alkaline phosphatase, one of the main enzymes secreted by preosteoblasts and
osteoblasts when depositing bone. After staining with alkaline phosphatase, six embryos
demonstrated signs of missing ossicles due to the implantation of a noggin-soaked bead
(Figure 8). Figure 8A depicts one of these embryos that had faint alkaline phosphatase
staining suggesting a condensation was present, however complete ossification had not
yet occurred (white arrow). In another embryo that was fixed at HH stages 38 there was a
large gap in the ring of scleral ossicles (Figure 8E, F). In the embryo that survived the
longest (HH stage 41) the gap created by the missing ossicle was reduced because the
adjacent ossicle grew very large to complete the ring of scleral ossicles (Figure 8C&D).
As shown in Figure 8, noggin bead implantation caused a range of effects on scleral
ossicles, such as complete inhibition of condensation formation (Figure 8C&E) as well as
effects on condensation size causing delay in osteoblast differentiation (Figure 8A).
Upon discovering that certain ossicles grew larger in the eyes with a missing
ossicle, a comparison in surface area was performed. If it appeared that the ossicle
directly next to the missing ossicle was larger than the control, then the surface ofthat
ossicle was measured and compared to the control side (Figure 8C&D) (Table 4). The
surface area of the ossicle in the control eye was smaller (0.886 mm2) than the ossicle that
was adjacent to a missing ossicle (1.465 mm2). If it appeared that the ossicles directly
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adjacent to the missing ossicles were not larger than the controls, then the next group of
induced ossicles were compared (Figure 8A&B, ossicles 1,2, and 3) (Table 4). The
surface area of the group of ossicles that were induced directly after the missing ossicle is
larger (m= 0.416 mm2, n=3) than the control ossicles in the same location (m=0.258 mm ,
n=3). In some cases, the ossicles in the control eye were approximately equal in surface
area to the ossicles in the experimental eye (Figure 8E&F) (Table 4). In this case,
compensation for the missing ossicle did not occur. These results indicate that, in some
cases, the condensation(s) that are induced immediately after the group of ossicles where
bead implantation was conducted are able to grow larger (Table 4).
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Table 4: Comparison between the eyes of individual embryos that were affected by the











































































m = 0.795 mm2
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Figure 8: Alkaline phosphatase stained embryos after bead implantation. (A) HH stage
39 embryo after bead implantation (white arrowhead) with a missing condensation or
delayed ossification. The following group of ossicles to be induced have grown larger
(numbers 1, 2, 3). (B) Control eye of the HH stage 39 embryo with a complete ring of
condensations. (C) HH stage 41 embryo after noggin bead implantation with a small gap
where bead implantation occurred (white arrowhead) and larger ossicle (black arrow)
compensated to fill the gap. (D) HH stage 41 embryo control eye with a complete ring of
condensations. (E) HH stage 38 embryo after noggin bead implantation (white
arrowhead) with a missing condensation. (F) Control eye with a complete ring of






3.2 Determining if iridian hedgehog is present during the induction of scleral ossicles
In order to ensure the in situ hybridization protocol was optimized, shh probe was
used and found in the feather buds in a similar pattern observed by previous studies
(Harris et al, 2002) (Figure 9A). Therefore the protocol was determined to be producing
reliable results. In order to determine if shh is the only Hedgehog family member present
during the induction of scleral ossicles, indian hedgehog probe was also used. Indian
hedgehog was not found at HH stages 33, 35/36, and 38 (Figure 9B and Table 5).
Although the scleral papillae and surrounding eye tissue had no ihh expression, signal
was demonstrated in other locations of the embryo such as the developing mandible
(Figure 9C). Ihh has a unique expression pattern, where expression stopped at the most
distal end of the beak. This suggests that ihh is likely not involved in the development of
scleral ossicles.
Table 5: Ihh in situ hybridization expression pattern in embryos HH stages 33, 35/36,
and 38
Stages indian hedgehog
Stage HH 33 - No expression in the eye
Stage HH 36 - No Expression in the eye;
expression located in the mandible




Figure 9: Location of shh and ihh mRNA through whole-mount in situ hybridization
expression. (A) Predicted shh expression pattern found in the developing feather buds of
a HH stage 36 embryo; (B) no indiati hedgehog expression present in the papillae (black
arrowheads) or surrounding eye tissues of a HH stage 36 eye; (C) ihh in the developing
mandible with unique loss of expression at the distal tip of the mandible (dashed line).
Scale bar in A represents 100 µp?, and 400 µ?? in B and C.
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3.3 Determining where shh is received through the expression pattern of the
Hedgehog family receptor patched.
After an initial in situ hybridization on HH stages 33, 35, 38 in which ptc expression
was identified at HH 35, a more extensive investigation was carried out on a wider range
of stages (HH 30-HH 40) (Table 6). No ptc expression was shown in HH stages 30
through 34 (Figure 10A). Ptc expression is first detected in the papillae at HH stage 35
(Figure 10B). As the embryo develops through HH stage 35 and into HH 36, the
expression declines in the papillae and appears to begin in the surrounding mesenchyme.
At HH stage 36 the expression ofptc is both in the papillae and in the surrounding
mesenchyme of all the papillae that have not started degenerating (Figure 10C). At HH
stage 37 the papillae have completely degenerated and condensation formation begins.
~Noptc expression was detected at this stage (Figure 10D). Similarly no ptc expression
was shown in HH stages 38 through 40. Two controls were also performed; a sense-probe
control and a no-probe control. In both of these control experiments no ptc expression
was detected (Figure 10E&F). This result suggests that shh and ptc are both present
during the inductive stages (HH 35 and 36) of scleral ossicle development and that shh
likely signals to both the epithelium and the mesenchyme.
To further analyze this ptc expression pattern, whole-mount in situ hybridization
tissue was sectioned using a cryostat. In serial sections, ptc expression is clearly visible in
the papillae and in a region of epithelium adjacent to the papillae (Figure 10G&H). In
addition, ptc was detected in the mesenchyme below the papillae as well as in the
adjacent mesenchyme (Figure 10G&H). These results suggest that shh signal is received
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by a wider range of epithelium than just the papillae and is also received by the
mesenchyme directly below and adjacent to the papillae.
Table 6: Patched in situ hybridization expression pattern in the eyes of HH stages 30
through 40
Embryonic Stage Ptc Expression
HH 30 (6.5-7 days)
HH 31 (7-7.5 days)
HH 32 (7.5 days)
HH 33 (7.5-8 days)
HH 34 (8 days)
HH 35 (8.5-9 days)
HH 36 (10 days)
HH 37 (11 days)
HH 38 (12 days)







Expression in the papillae and starting to appear in
the surrounding mesenchyme.
Expression reduced in the papillae and expression






Figure 10: Location of ptc mRNA based on whole-mount in situ hybridization
expression in eyes of embryos from HH stages 34-37 (A) HH stage 34 embryo with no
expression in the papillae (black arrowheads); (B) HH stage 35 embryo with expression
in two papillae as well as a third papillae beginning to show expression in the underlying
mesenchyme (black arrowheads); (C) HH stage 36 with expression located both in the
papillae and surrounding the papillae in the underlying mesenchyme; (D) HH stage 37
embryo with early condensations (an outline around one condensation) and no ptc
expression; (E) HH stage 36 sense probe hybridization with no expression shown in the
papillae (white arrowheads); (F) HH stage 36 hybridization performed without probe and
therefore no expression is shown in the papillae (white arrowheads), however a small
amount of precipitate (not signal) from the colour reaction is shown (black arrowhead);
(G) cryostat section of the HH stage 36 hybridized tissue showing epithelial signal in the
papillae (black arrowhead) as well as underlying mesenchymal signal (white
arrowheads), bracket indicates the scleral cartilage; (H) cryostat section of HH 36
hybridized tissue located directly next to a distinct papillae showing more intense
expression in the epithelium adjacent to the papillae (black arrow) and localized
mesenchymal expression directly beneath the epithelium (white arrow), bracket indicates
scleral cartilage. Scale bars in A-C represent 250 µ??, D is 500 µ??, E and F are 200 µ??,
















3.4 Determining if other candidate genes scleraxis and msx2 are present during the
induction and growth of scleral ossicles
In order to determine if scleraxis is present during the induction of scleral ossicles
whole-mount in situ hybridization was performed. After an initial in situ hybridization on
HH stages 33,36, and 38 in which scleraxis expression was identified at HH 36, a more
extensive investigation was carried out on a wider range of HH stages 30- 40 (Table 7).
No scleraxis expression was detected in HH stages 30-34 (Figure 1 IA). HH stage 35 was
the first stage when expression was detected and this expression continued to HH 36
(Figure 1 1B&C). At HH stage 37 the papillae have completely degenerated and
condensation formation begins. No scleraxis expression was detected at this stage (Figure
HD). Similarly no scleraxis expression was shown in HH stages 38 through 40. A sense
probe and a no probe control were both performed and no expression was detected (not
shown). To further analyze the scleraxis expression pattern, tissue after whole-mount in
situ hybridization was sectioned using a microtome. In 5 µ?t? serial sections, scleraxis
expression is clearly visible in the papillae and in the adjacent epithelium alone and not in
the underlying mesenchyme (Figure 1 IE). These results suggest that scleraxis is
important during HH stages 35 and 36 when the papillae are the longest and that scleraxis
is not involved in the induction of scleral condensations or the growth of scleral ossicles.
Due to its role in maintaining the proliferation of osteoblasts in the osteogenic fronts
of developing mice calvaría, msx2 was investigated for its potential role in the expansion
and growth of scleral condensations. In order to determine if msx2 is present during the
condensation growth period, an initial in situ hybridization on HH stages 35/36
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(induction stage), HH 38 (early condensation stage), and HH 40 (late condensation stage)
was performed. Msx2 expression was not found in the eye at any of the stages
investigated (Figure 12A) but was detected in the developing mandible in a unique
expression pattern with the most distal tip of the beak lacking expression (Figure 12B).
This result suggests that msx2 is likely not involved in the induction or growth of scleral
condensations.
Table 7: Scleraxis and msx2 in situ hybridization expression pattern in embryos at HH
stages 30 through 40.
Stage
HH 30 (6.5-7 days)
HH 31 (7-7.5 days)
HH 32 (7.5 days)
HH 33 (7.5-8 days)
HH 34 (8 days)
HH 35 (8.5-9 days)
HH 36 (10 days)
HH 37 (11 days)
HH 38 (12 days)
HH 39 (13 days)
















No expression in the
eyes
No expression in the
eyes; expression in the
mandible and feather
follicles
No expression in the




Figure 11: Location of scleraxìs mRNA based on whole-mount in situ hybridization
expression in eyes from HH stages 34-37. (A) HH stage 34 embryo with no signal present
in the papillae (arrow), black arrowhead represents precipitate from the colour reaction
and is not signal; (B) HH stage 35 embryo showing expression of scleraxìs specifically in
the two adjacent papillae (white arrowheads); (C) HH stage 36 embryo with expression in
the papillae (white arrowheads); (D) HH stage 38 embryo showing ossicles (outlined by
the hashed line) without any scleraxis expression; (E) 5 µ?? section of a piece of
hybridized tissue showing the scleraxis signal in the papilla (arrow) and not in the
underlying mesenchyme. Scale bar in A and B represent 100 µ??, C is 200µ??, D is 100




Figure 12: Location of msx2 expression in the chicken head. (A) Anterior region of a HH
stage 39 eye was removed to confirm the lack of expression in the condensations (arrow).
(B) At HH stage 40 beak with a unique expression pattern, the most distal part of the
mandible is clear of expression (line indicates border of signal); feather follicles also
show expression. Scale bars in A and B represent 200 µ??.
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4.0 Discussion
4.1 Application of exogenous noggin inhibits ossicle formation
Noggin is a secreted protein used in developmental pathways such as the limb, ear,
and skeleton, for the inhibition of the bone morphogenetic protein family. Noggin inhibits
BMP2, BMP4, and BMP 7 by binding to these proteins and therefore rendering them
inactive (Zimmerman et al, 1996). This specific property of noggin, makes it a very
useful feedback molecule in pathways that include the BMP signalling molecules.
In limb development, noggin plays an important role. Noggin, with the BMP family,
the BMP receptors, and other TGFßs form a feedback loop that is crucial in anterior-
posterior patterning of the limb. Digit chondrogenesis is regulated by this feedback.
Noggin is crucial in this feedback loop for the maintenance of the proper size and shape
of the developing cartilaginous digits (Merino et al, 1998).
Noggin was also used in an experimental setting to demonstrate the effects ofBMP
knockout during the development of the inner ear. BMP4 is expressed during a variety of
time points in the developing inner ear in chicken embryos (Chang, et al, 1999). In order
to understand the specific role BMP4 has in the development of the inner ear, noggin can
be used to inhibit its effects. A noggin-soaked aff-gel bead was implanted into the
developing inner ear. This application inhibited the BMP4 normally expressed in the
inner ear, and produced a variety of mutant phenotypes. These mutant phenotypes
demonstrated that BMP4 plays a crucial role in the sensory and non sensory structures
(semicircular canals) of the inner ear. Also, it was determined that BMP4 plays a crucial
role in the patterning of the cristae of the inner ear. With the ability to knock out BMPs
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important information can be gained about their role in development including systems
such as scleral ossicles.
During condensation formation, BMP2, 4, and 7 are important molecules for the
recruitment ofmesenchymal cells into the skeletogenic condensation (Hall and Miyake,
2000). Recruitment of cells into a condensation is a required step for the proper
development of skeletal tissues. However, there is a limit to the number of cells required
in a condensation in order for cellular differentiation to occur. Therefore noggin is likely
present during condensation formation to inhibit the BMPs at the appropriate time and
subsequently favour differentiation indirectly resulting in condensation formation.
In my research, the exogenous application of noggin during the development of scleral
ossicles had a number of effects. Firstly, the ossicle number was typically lower in the
bead implantation eye than in the control eye (Table 4). This result alone is however not
conclusive of noggin's effect, since Franz-Odendaal (2008) showed that there is a
naturally occurring variance in the ossicle number between the right and left eyes of
chicken embryos . However, there was also a noticeable difference in the morphology of
the condensations in the experimental eye compared to the control eye. A gap in the ring
of ossicles was shown in the eyes of embryos that had a noggin-bead implantation
(Figure 8). Moreover, this gap (corresponding to a missing ossicle) could always be
found in the mesenchyme underneath the epithelial location of the prior bead
implantation. In one of the embryos, it appeared as though a condensation was present
(Figure 8A) however ossification had not yet occurred. The faint alkaline phosphatase
staining could represent a bead implantation that has delayed the condensation from
reaching a critical size needed for differentiation of osteoblasts to occur. This delay in
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ossification was likely due to slight differences in the timing of the bead implantation.
HH stage 35 is defined as day 8.5 to 9, therefore it has a 12 hour range. A bead
implantation toward the end of this temporal range could have led to delayed osteoblast
differentiation within the condensation rather than the inhibition of condensation
formation. Inhibition of a completely ossified ossicle was shown in 100% (6/6) of the
embryos that survived to HH stage 38 (or later).
These results are strengthened by the consistent controls performed with each bead
implantation. The amount of noggin on each bead was controlled by maintaining a
concentration of 1 .0 µg/µl per 30 beads of approximately the same size. There were two
separate controls for these bead implantations. The first control was achieved by
comparing the right and left eyes of the same embryo. One of the eyes had a noggin bead
implantation, while the other eye is not affected by the local application of noggin. This
way we can compare the number and size of the ossicles in the right and left eye for each
embryo (Figure 8 A&B, C&D, and E&F). A second control experiment was performed to
further demonstrate that the bead implantation alone was not the cause of the inhibitory
effect shown in this experiment. Affi-gel beads of the same size were soaked in PBS
alone and then implanted into the eyes in the exact same manner as the noggin beads.
When PBS-soaked beads were implanted into the eye, no inhibition of ossicles was
observed (Figure 7). In this case, 100% (1 1/11) of the embryos that survived post HH
stage 38 with PBS-soaked beads showed no ossicle inhibition. Therefore the inhibition of
ossicle formation must be attributed to the exogenous application of noggin, which
inhibits BMPs in the local area of ossicle development.
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4.2 BMP involvement in the developmental pathway of scleral ossicles
The BMP family is known to be involved in a variety of developmental systems.
During condensation formation, BMP2, 4, and 7 are important molecules for the
recruitment of mesenchymal cells into the condensation (Hall and Miyake, 2000).
Secondly, BMPs are produced as signalling factors in a variety of epithelial signalling
centres such as during tooth development (Thesleff, 2003). The BMP signal induces the
underlying mesenchyme to condense or become competent for further inductive events.
The mesenchyme then produces a reciprocal BMP signal, BMP4. BMP4 signals back to
the epithelium to regulate the formation of the dental placode. Later, this BMP4 signal
produced in the mesenchyme will aid in the formation of the enamel knot. Finally, BMP2,
4, and 7 are all produced in the enamel knot and released as signalling factors. Some of
those BMPs act in an autocrine manner, signalling to the epithelium itself and helping to
maintain the enamel knot. Other BMPs signal to the mesenchyme, which will eventually
result in further morphogenesis of the dental epithelium.
A second signalling centre that uses the BMP family of genes is in the developing
limb, in the zone ofpolarizing activity. This area is responsible for the patterning of the
hand bones (thumb to little finger). In this region it is suggested that sonic hedgehog and
BMP2 work together to control the patterning and development of the bones in the hand
(Mariana and Martin, 2003). Finally, BMPs (specifically BMP 2 and 4) are important
molecules in patterning and development of feathers (Noramly and Morgan, 1998).
BMP2 works as an inhibitory molecule to ensure the "track-like" pattern of the
developing feathers. BMP2 and 4 then continue to regulate feather growth by
determining the size and shape of the feather bud. The size and shape of the feather bud is
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likely not determined by BMPs alone; but may also involve the fibroblast growth factor
family.
The role ?? BMP in these epithelial-mesenchymal interactions makes it an excellent
candidate gene to be involved in the development of scleral ossicles. The precise role that
the BMP family of genes is playing during the development of scleral ossicles is still
relatively unclear and requires further investigation. However, a few important insights
can be gained from the results shown in this study. Firstly, the papilla that was exposed to
noggin was not affected. When papillae are exposed to cyclopamine, a Hedgehog
inhibitor, they degenerated (Franz-Odendaal, 2008). However, this was not the case when
BMP inhibition occurred. This would suggest that the BMP family of genes is not
required for the maintenance of the developing papillae. Despite having no effect on the
development and maintenance of the papillae, inhibition ??BMPs resulted in the loss of
the underlying ossicle and the expansion of other ossicles in the eye. The loss of a scleral
ossicle suggests that the BMP family is likely involved in the induction or subsequent
development of scleral ossicles.
Since the noggin-soaked bead was placed directly under the epithelium, the noggin
protein can diffuse to the adjacent epithelium and to the underlying mesenchyme.
Therefore, BMP signalling could be present in the papillae, underlying mesenchyme, or
deeper retinal pigmented epithelium (RPE) (Figure 13). The latter seems unlikely
considering that the absorbed noggin on the bead only diffuses a short distance. This
distance is demonstrated by the fact that only the ossicle directly underneath the bead is
inhibited. The noggin on the bead is unable to diffuse further and cause an effect on
surrounding ossicles. In addition the entire scleral mesenchyme and the scleral cartilage
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are relatively thick in comparison to the distance between papillae, therefore it is unlikely
that the noggin would diffuse across this distance to have an affect at the RPE. Therefore
I hypothesize that the BMP signals that were inhibited by noggin are likely present in the
epithelium, or underlying mesenchyme, or both. Further investigation is required, in order
to determine exactly where BMP is expressed. Expression ofBMP 2 and 4 was shown to
be slightly increased (3.5 fold and 2.7 fold respectively) at HH stage 36 through real-time
PCR (Franz-Odendaal, 2008). However, this increase was not considered important at the
time when compared to the drastic increase (30 fold) of shh expression at that stage. Also,
previous in situ hybridization results, by an honours student in the lab (M. Bauer),
showed that there was no expression ofBMP2 in the papillae or underlying mesenchyme
during the inductive stages of scleral ossicle development. My results have shown that
the BMP family of genes (most likely BMP2, 4, or 7) are involved in the induction and/or
development of scleral ossicles. Therefore I suggest that BMP7 is the most likely BMP















Figure 13: Possible locations for BMP signals during the development of scleral ossicles.
Blue arrow represents epithelial-mesenchymal interaction from the papilla. Green arrow
represents BMP involvement in the recruition of mesenchymal cells into the ossicle
condensation. Red circle demonstrates placement of a noggin-soaked bead and the
inhibitory effects that are possible on each of the BMP signalling pathways.
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4.3 Neighbouring ossicles demonstrate the ability to compensate for a missing ossicle
Alkaline phosphatase stain was used in this study to visualize ossicles after bead
implantation. This allowed for a comparison between the experimental vs. control eye of
the embryo. In general, it appears that timing of the bead implantation is very important.
If, the bead is implanted early during the induction stage then the papillae around papilla
8 or 9 are likely still in the process of inducing the underlying mesenchyme. Therefore,
the papillae directly adjacent to papilla 8 or 9 after bead implantation will be able to alter
its signalling and induce the formation of a larger ossicle. This would suggest that the
ossicle directly adjacent to the missing ossicle is much larger to compensate for the gap in
the ring (Figure 8 C). However, if bead implantation is performed slightly later (HH
35.5), induction of the underlying mesenchyme could already be underway at papillae 8
or 9 (Figure 2). In order to compensate for the inhibition occurring at papillae 8 or 9, the
next group ofpapillae to induce the underlying mesenchyme would have the means to
induce larger condensations (Figure 8A, group of ossicles marked by 1, 2, and 3). In
general, the ossicles in the surgery eye were larger than the identical ossicle in the control
eye (Table 4). There was one exception to this observation. In one individual, the control
side actually had larger ossicles (Figure 8 E&F). In this eye the gap in the ring of ossicles
on the bead implantation side remained present later in development, which demonstrates
that the surgery eye was not capable of compensation for the missing ossicle.
The concept of compensation suggests that the formation of a complete sclerotic
ring is important. This is further demonstrated in the scaleless mutant, in which despite
forming an average of three papillae (and often only one or two ossicles), the developing
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ossicles are grossly enlarged in an attempt to form a complete ring (Palmoski and
Goetinck, 1970). The importance of this ring is implied, since the eyes are a crucial organ
for most vertebrates. Moreover scleral ossicles are important for the accommodation that
occurs in the eye during depth perception. Therefore the unique patterning of
papillae/ossicle development could be explained evolutionarily. The delayed induction of
individual groups of papillae enables the ring of ossicles to gain many opportunities to
compensate for the potential loss or injury of an ossicle.
4.4 Sonic hedgehog is likely the only member of the Hedgehog gene family involved
in the induction of scleral ossicles
Our lab has shown that shh is present during the inductive HH stage 35 and 36 of
scleral ossicle development and that the inhibition of the Hedgehog family through
exogenous application of cyclopamine (a Hedgehog inhibitor), prevents ossicle formation
(Franz-Odendaal, 2008). These results suggest that shh likely plays a role in the
development of scleral ossicles. However, these findings do not eliminate the possibility
of other members of the Hedgehog family playing a role during this induction. Indian
hedgehog is another common vertebrate Hedgehog gene, which plays a role in a skeletal
development, albeit typically endochondral in nature.
Following the optimization of the in situ hybridization protocol, ihh was
investigated. However, ihh expression was not shown at HH stage 33, 36, or 38 (Figure
9B). The lack of ihh expression in the induction of scleral ossicles, suggests that the only
confirmed member of the Hedgehog family that is involved in this pathway is shh. Desert
hedgehog is the other vertebrate Hedgehog family member. It is typically expressed
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during sexual development and is therefore not likely playing a role in skeletogenesis.
Also, a search of the Gallus gallus genome indicates that dhh is not present in chickens
and possibly all birds and is therefore not a likely candidate.
Both expression of ihh and shh were found in the developing mandible at HH
stage 36. While shh expression was shown throughout the mandible, ihh demonstrated a
unique expression pattern in which the most distal end of the mandible was devoid of
signal (Figure 9C). This pattern may suggest a signal gradient that occurs during the
development of the mandible, but this interesting pattern is beyond the scope of this
study.
4.5 Sonic hedgehog acts as an autocrine and paracrine signal during the
development of scleral ossicles
Sonic hedgehog (shh) is common in many developmental systems, such as the
developing craniofacial skeleton and the limb. Shh is involved in the development of the
entire frontonasal and maxillary processes (Hu and Helms, 1999). Fluctuations in the
normal shh signalling during the development of these craniofacial bones is thought to
play a role in a variety of human genetic disorders such as cleft lip/palate and
hypertelorism. Inhibition ofshh causes the truncation of the frontonasal and maxillary
processes primordia affecting the mediolateral axis of the face resulting in cleft lip.
Conversely, overexpression ofshh can cause the structures in the midline (such as the
nasal bone) to duplicate and can also lead to a widening of the frontonasal and maxillary
processes known as hypertelorism. This suggests that accurate expression ofshh is
required during the development of craniofacial bone.
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A second example where correct shh signalling is required, is in the limb. Shh is
produced by the zone of polarizing activity (ZPA) and acts as a morphogen to produce
the anterior-posterior patterning seen in the digits (Freeman, 2000). Recent studies
suggest however, that a more complex signalling pathway occurs during the development
of the digits (McGlinn and Tabin, 2006). Shh is now thought to have both paracrine and
autocrine roles. The most anterior digit (digit 1) is not affected by shh and never produces
shh signal. Moving in a posterior direction, digit 2 and half of digit 3 never produce shh
signal. However these digits rely on shh signal for their patterning, suggesting that shh
signal is made at a more posterior location and received by these anterior digits, in a
paracrine signalling manner. Finally the most posterior digits 4 and 5 (and half of digit 3)
produce shh signal and also receive that signal for patterning, in an autocrine signalling
manner. In the 4 digits where shh is received, it acts on both the mesenchyme and the
epithelium to form the correct patterning of skin, bones, and muscle along the anterior-
posterior axis. These findings demonstrate that shh can act as both an autocrine and
paracrine signal in developmental systems.
In order to better understand the role that shh plays during the induction of scleral
ossicles, the location and distribution of the Hedgehog receptorpatched (ptc) was
determined. Although ptc is the ligand receptor for the entire Hedgehog family of
proteins, it was previously determined that only shh is present during ossicle induction.
The location of the shh receptor indicates the tissue on which shh is acting. During the
induction of scleral ossicles, the expression of the Hedgehog receptorptc in both the
epithelium and the mesenchyme suggests that shh is likely acting in both an autocrine and
paracrine manner (Figure 14). There are several pieces of evidence for this signalling
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pattern based on the results obtained in this study. Firstly, in situ hybridization was
performed on embryos HH stages 30 through 40. Ptc expression was only shown in HH
stage 35 and 36 (Table 6), which corresponds directly to the expression of shh shown by
Franz-Odendaal (2008). Secondly, the expression ??ptc in the papillae and the
mesenchyme seems to have a temporal component. Meaning that, first ptc is expressed
strictly in the papillae (HH stage 35) (Figure 10B) suggesting that shh appears to act on
the papillae itself first. Then the expression is shown both in the papillae as well as the
underlying mesenchyme (HH stage 36).
During HH stage 35 when the expression is located in the papillae, expression was
also shown in the epithelium adjacent to the papillae (Figure 10H). This epithelial
expression demonstrates that shh has two possible roles. Firstly, shh could be signalling
to the papillae as a positive feedback signal to produce more shh. Secondly shh could be
acting on the papillae and surrounding epithelium in order to maintain the structure of the
papilla itself. Previous proliferation studies show that early in papillae development, the
entire papillae is proliferating; as the papillae matures only the outer most cells of the
papillae are proliferating (Franz-Odendaal, 2008). Therefore shh could be signalling to
maintain the proliferation occurring throughout the papillae at HH stage 35 and as the
papillae matures into HH stage 36 the proliferation is decreased correlating to a decrease
in shh activity as well as ptc expression in the papillae. At the point (HH stage 36) ptc
expression is also located in the underlying mesenchyme (Figure 10C). This finding
suggests that not only is shh maintaining the papillae structure, but it is also signalling to
the mesenchyme to likely induce condensation formation. All of these findings suggest
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that shh signalling during the development of scleral ossicles has a dual method of action














Figure 14: Schematic showing suggested autocrine and paracrine signalling pathway for
shh during scleral ossicle development based on the in situ hybridization expression of
the ptc receptor. Shh is produced in the papillae and then signals in an autocrine manner
to the epithelium itself (arrow 1). Shh signals to the epithelium of the papillae and
surrounding epithelium (arrows 2). Shh undergoes paracrine signalling to the underlying
mesenchyme (arrow 3).
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4.6 The role of scleraxis during scleral papillae development
Scleraxis is a member of the basic helix-loop-helix (bHLH) family of
transcription factors and has been shown to play an important role in cell
differentiation, proliferation, and development of connective tissue such as tendons
and ligaments (Espira et al, 2009). Studies have shown that the expression pattern of
scleraxis in early embryogenesis is located mainly in the mesoderm, for example, in
developing somites (Burgess et al, 1995). Specifically scleraxis expression was
shown in the somites that give rise to the ribs and vertebrae. However, as soon as
ossification beings in these areas, scleraxis expression is consistently downregulated
(Cserjesi et al, 1995). Also scleraxis is known to be a marker of mesodermally
derived mesenchyme for the axial and appendicular skeleton, particularly in areas that
form ligaments and tendons. These findings suggest that scleraxis is important in
support structures such as; connective tissue of the spine and ribs, tendons, and
ligaments.
In situ hybridization results in this study demonstrated that the expression of
scleraxis was limited to HH stages 35 and 36 (Table 7). These stages are when the
papillae are the largest and when induction is occurring. Despite papillae being present
at HH stage 30 through 34, scleraxis was not expressed in any of these stages (Figure
1 IA). The absence ??scleraxis expression in these early papillae stages is likely due to
the fact before HH stage 35 the papillae are still relatively small and remain close to
the conjunctiva. By HH stage 35 the papillae are large and form a distinct elongation
of conjunctival epithelium (Figure 15). This elongation of the epithelium likely needs
more structural support. Later in HH stage 36 the group of papillae over the ciliary
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artery may start to degenerate. Scleraxis expression is not found in papillae that begin
degenerating. Based on the sectioning results scleraxis expression is located in the
papillae alone, not in the underlying mesenchyme (Figure 1 IE). All of these findings,
















Figure 15: Schematic showing hypothesized scleraxis involvement in the development
of scleral papillae based on in situ hybridization expression. Scleraxis is localized to the
epithelium when the papillae structure is large (purple).
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4.7 Msx2 not involved in condensation growth
In vertebrates, the msx gene family consists of three members {msxl, msx2, msx3),
however only msxl and msx2 are widely expressed throughout the development of
skeletal tissues such as the calvariae (Alappat et al, 2003). Specifically, msx2 is found in
the suture mesenchyme and dura of the developing calvariae. In a wild type mouse skull,
msx2 is required to maintain the proliferation of the osteoblasts present at the growing
osteogenic fronts of calvariae bones (Liu et al, 1999). These results suggest that msx2
plays a crucial role in the balance ofproliferating osteoblasts and differentiating
osteocytes in the developing intramembranous calvariae. Due to its involvement in the
developmental pathway of these neural crest derived intramembranous bones, msx2 was
hypothesized to be involved in the expansion and growth of scleral ossicle condensations
and scleral ossicles.
In order to determine if msx2 was involved in the growth and expansion of scleral
ossicles, HH stages 35 and later were investigated. Expression oîmsx2 was not found at
HH stage 35 during induction, or at later stages (HH 38 through HH 40) when
condensation growth was occurring (Table 7). Msx2 expression was shown in other areas
of the HH 40 embryos such as the mandible and feathers (Figure 12B). These results
suggest differences in the molecular signals involved in the growth of specific
intramembranous bones such as calvariae and scleral ossicles.
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5.0 Conclusions
Bone development is a highly regulated, step-wise process, which involves a
number of tissues and hierarchal signalling events. In order to understand the process of
intramembranous bone development, different intramembranous bones must be studied
and compared. Although a variety of information exists pertaining to the development of
calvariae (the intramembranous bones of the skull), in comparison very little information
exists regarding the development of scleral ossicles (intramembranous bones of the eye).
This study succeeded in unravelling more of the molecular pathway involved in the
development of scleral ossicles, which has been a 30 year mystery until the research
performed by our lab.
Firstly, the BMP family of genes is suggested to be crucial in the induction and
subsequent development of scleral ossicles. Through local inhibition of the BMP family
of genes via exogenous application of noggin, scleral ossicle formation was inhibited
(Figure 16). This result suggests that scleral ossicles are unable to form without BMPs.
Despite gaining the understanding that BMPs are crucial for the development of scleral
ossicles, it is still uncertain how the BMP signalling is occurring and what specific BMPs
are involved. Based on the literature, BMP 2, 4, and 7 are most likely. However, based on
the previous real-time PCR and in situ hybridization evidence from the Franz-Odendaal
lab (Franz-Odendaal, 2008), BMP 2 and 4 have a minor role in ossicle development;
BMP7 is the next most likely candidate. Three possible pathways are suggested. First,
BMPs might act via an epithelial mesenchymal interaction between the papillae and the
underlying mesenchyme. Second, BMPs might be signalling in the mesenchyme alone
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and could be responsible for the recruitment of mesenchymal cells into scleral
condensations (Figure 16). Finally, BMPs interact via an epithelial mesenchymal
interaction with the RPE and the overlying scleral mesenchyme. Due to the large distance
between the bead placement under the epithelium and the RPE (beneath the scleral
cartilage), this pathway is not likely. Further investigation is required in order to better
understand the role that the BMPs play during the development of scleral ossicles.
Through inhibition of a scleral ossicle, observations were made on the ability of
the ring of ossicles to compensate for a missing ossicle. The possibility for compensation
of scleral ossicles shown in this study, demonstrates a potential evolutionary reason for
why the scleral papillae and ossicles are patterned in such a sequential way. The delay
between the development of groups of papillae/ossicles could allow the sclerotic ring to
compensate for the loss of an ossicle or potential injury. This is a vital adaptation because
the eyes are such an important organ for most vertebrates and scleral ossicles are
important for accommodation in the eye. It would follow, that there would be
mechanisms in place to ensure that the development of the eye occurs in a way that can
consistently produce a functional eye, despite potential disruptions to the developmental
system.
Through in situ hybridization a variety of genes were investigated for their
involvement in the development of scleral ossicles. Firstly it was demonstrated that shh is
likely the only member of the Hedgehog family involved in the induction of scleral
ossicles. Indian hedgehog could also have been playing a role during this induction
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however my research demonstrated that indian hedgehog is not present during the
induction of scleral ossicles (Figure 16).
A potential role for shh during the induction of scleral ossicles has been
suggested. The in situ hybridization expression pattern of the Hedgehog receptor ptc was
determined and both an epithelial and mesenchymal component were discovered. This
suggested that shh is likely acting in an autocrine fashion, signalling to the papillae likely
for maintenance and proliferation. Also, shh is likely working as a paracrine factor,
signalling via epithelial-mesenchymal interaction to the underlying scleral mesenchyme
in order to assist in the formation of scleral condensations (Figure 16).
Finally, other candidate genes such as scleraxis and msx2 were investigated via in
situ hybridization. It is suggested that contrary to the important role msx2 plays during the
development of calvaría, msx2 does not play a role in the development of scleral ossicles.
In contrast, we were not predicting the involvement of scleraxis, since its presence is
usually shown in systems not related to bone development. However, scleraxis
expression was shown during HH stage 35 and 36 in the papillae (Figure 16). This result
suggests that scleraxis is likely not involved in the inductive signalling events of scleral
ossicle development. However, scleraxis is suggested to play a role in the support of
mature papillae; possibly in conjunction with tenascin (unpublished, Franz-Odendaal).
In summary, this research has provided much more information regarding the
molecular pathways involved in scleral ossicle development (Figure 16), and therefore
has also contributed to the understanding of intramembranous bone development, in
general. To better understand the complete developmental pathway involved in scleral
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ossicles the following research should be completed, which was outside the scope ofmy
thesis. Our lab is currently performing a comparative microarray experiment to further
investigate the development of scleral ossicles. Further in situ hybridization experiments
should be performed, specifically with BMP7, to attempt to highlight the presence of a
specific member of the BMP family. As well, in situ hybridization experiments could be
performed to locate the receptors of the BMP family in order to determine which tissues
the BMPs are acting on. Finally, other gene families should be investigated such as the
fibroblast growth factor (FGF) family. All of this information will help to complete the
















Figure 16: Suggested molecular pathway involved in the development of scleral ossicles.
Potential signalling events from the BMP family of genes are indicated in blue. Inhibitory
effects on the BMP family via noggin bead implantation at the epithelium shown in red.
Shh autocrine (to the papilla) and paracrine (to the mesenchyme) signalling demonstrated
by orange arrows based on the in situ hybridization expression of the Hedgehog receptor
ptc. Scleraxis is found in the papillae (purple) for support of the papilla. Indian hedgehog
and msx2 expression were not found and therefore are likely not involved in this
developmental pathway (shown by red X's).
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6.25 g of Luria-Bertani (LB) Broth (Difco, 244620)
3.75 g of agar (Difco, 214530).
250mlofdH2O.
Heat until dissolved and then autoclave.
- After autoclaving and the solution has cooled, add 0.001% ampicillin (Sigma,
A6140).
- Stirred well and then pour the solution into sterile petri-dishes and allow to cool
until solid.




Place 2 ml from each overnight culture into individual eppendorf tubes. Spin these
tubes for one minute, twice to obtain a large pellet. Remove supernatant.
- Add 250 ul of cold buffer pH8 to each sample and re-suspend pellet in the buffer.
- Add 250 µ? cold lysis solution and mix. Place on ice for 5 minutes.
- Add 250 µ? of cold IM potassium acetate and mix the solution until cloudy. Place
on ice for 5minutes.
Centrifuge for five minutes and collect the supernatant in a fresh tube.
- Add 200 µ? of the bottom layer of phenol-chloroform to the supernatant and mix
for 30 seconds.
- Centrifuge the sample for five minutes and collect the top layer of solution with a
pipette in a new tube.
- Add an equal volume (approximately 650 µ?) of isopropanol, mix briefly and let
stand for two minutes at room temp.
Centrifuge for five minutes and discard the supernatant. Add 200 µ? of cold 95%
ethanol and invert the tube gently.
- Centrifuge for five minutes and remove the supernatant. Allow the final pellet to
dry completely at room temperature before adding 30 µ? dH20. Store the sample
at -2O0C.
Plasmid isolation recipes:
Cold Buffer (made fresh) 1 ml
- 5OmM TrisCl
- 1 OmM EDTA (Sigma, E5 1 34)
- 1 00µg/ml Ribonuclease A (Sigma - R4642)
Lysis solution (made fresh) 1 ml
- 100µ1??2??3??
- 100 µ? 10% SDS (Sigma, L4390)
- 800µ1 distilled water)
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Appendix C
Standard RNA labelling reaction:
This reaction is done using a prepared kit (Roche - 1 1 175025910)
- Add 1 µg of the purified DNA sample to a RNase free tube. Then, add enough
DepC treated water to the vile for a total volume of 13 µ?.
- Add the following reagents to the DNA sample:
o 2 µ? of 1 OX NTP labelling mixture
? 2µ1 of 1 OX transcription
o 1 µ? of protector RNase inhibitor
o 2 µ? of RNA polymerase (T7 or SP6)
- Mix the reagents and DNA sample gently and then place them at 370C for 2
hours.
Add 2 µ? of DNaseI to the tube and place back in the 370C incubator for 1 5
minutes.
- Stop the reaction by adding 2 µ? of 0.2 M EDTA (pH 8)
Place 1 µ? of the now labelled RNA into a new vial. Store the rest of the labelled
RNA probe at -2O0C.
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Preparation of probe dilutions for the labelling detection protocol
Using RNA Dilution buffer, dilute the 1 µ? of labelled RNA from the previous
step so that the final concentration is 10 ng/µ?.
o Dilution buffer: Mix in a sterile RNase free tube, DepC treated water, 2OX
SSC, and formaldehyde in the ratio of 5:3:2 respectively.
Using the dilution buffer and the following table, prepare 5 dilutions of the
previous RNA solution.











2 ? 18 1:10 lng/µ?
198 1:100 lOpg/µ?
4 15 35 1:3:3 3?^µ1
45 1:10 lpg/µ?
Proceed to the DIG high prime DNA labelling and detection protocol
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Appendix D
DIG high prime DNA labelling and detection protocol
- Place 1 µ? of each RNA probe dilution to the membrane and fix the nucleic acids
to the membrane by baking them for 30 minutes at 12O0C in a sterile glass dish.
- Transfer membrane to a plastic petridish with approximately 20 ml of Maleie acid
buffer (enough to cover the membrane). Incubate at 2O0C with shaking for two
minutes.
- Incubate at 2O0C in blocking solution with shaking for 20 minutes.
- Wash for five minutes in TBST at 2O0C with shaking
- Incubate at 2O0C in 10 ml of antibody solution for 30 minutes with shaking.
- Wash with washing buffer at 2O0C with shaking for 1 5 minutes, twice.
Equilibrate for five minutes in detection buffer at 2O0C with shaking.
Incubate at room temperature in the dark in 10ml of freshly prepared colour
substrate solution, no shaking.
Observe colour reaction over a 30 minute -12 hour period.
- To stop the reaction, place the membrane in TE-buffer (pH8) at 2O0C with
shaking for five minutes.
Store the membrane in a ziplock bag at 40C.
DIG high prime DNA labelling and detection recipes
Washing Buffer pH7.5 100 ml
- 0.1 M Maleic acid (Fischer Scientific, 064402) 1.16 g
- 0.15MNaCl (Sigma, S3 01 4) 0.876 g
- 0.3% Tween20 (Sigma, P9416) 0.3 ml
- 0.0 1 % DepC treated water
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Maleic acid buffer pH7.5 100 mi
0.1 M Maleic acid
0.15MNaCl
0.01% DepC treated water
1.16g
0.876 g
Detection buffer 100 mi
0.1MTris-HCl
0.1 M NaCl
0.01% DepC treated water





0.01% DepC treated water
1 ml of IM stock
0.2 ml of 0.5M stock
Blocking solution (made fresh) 100 ml
2% Sheep serum (Sigma, S2263)
3% Instant skim milk powder (Carnation Brand)




Antibody solution (made fresh) 10 ml
1:5000 Anti-Digoxigenin -AP (Roche, 12930020)




Colour substrate solution (made fresh) 10 ml
- Sigma Fast tablet, NBT-BCIP (Sigma B5655) 1 Tablet
- Distilled water 10 ml
Shake vigorously (in the dark) until dissolved.
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Appendix E
Whole-mount in situ hybridization protocol
Day 1 : Collect embryos for storage
- After staging, fix embryos in 4% Paraformaldehyde in IX PBST made in DepC
treated water.
- Wash twice for 1 0 minutes wash in IX PBST on ice
Dehydrate embryos through MeOH series on ice as follows:
15 minutes in 25:75 MeOH/lX PBST
15 minutes in 50:50 MeOH/PBS
15 minutes in 75:25 MeOH/depc H20
Stored in 100% MeOH overnight at -20C in 50ml tube
Bisect heads
Réhydrate embryos through MeOH series on ice as follows:
15 minutes in 75:25 MeOH/depc H20 on ice
15 minutes in 50:50 MeOH/PBS on ice
15 minutes in 25:75 MeOH/lX PBST on ice
- Wash twice for 1 0 minutes in 1 ? PBST at room temperature with shaking in 50
ml tube
- Bleach for half hour in 10% Hydrogen Peroxide/lx PBST at room temperature
with shaking.
- Wash three times for 10 minutes in Ix PBST at room temperature with shaking
- Store at -200C until ready to continue with the protocol.
Day 2: Hybridization Step
- Wash three times for 10 minutes in Ix PBST at room temperature with shaking
- 30 minutes in 50ug/mL Proteinase K in IXPBST at room temperature with
shaking
- Fix heads for 20 minutes in 4% PFA/PBST and 0.25% glutaraldehyde/PBST
(50:50) at room temperature
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- Wash twice for 10 minutes in 10X PBST at room temperature with shaking in 50
ml tube
- Hybridisation step: add 0.5 ul probe to 1 0 mL of 1 X Prehyb (with Yeast tRNA
and heparin freshly added) and incubated at 600C overnight.
Day 3: Antibody Step
- Wash three times for 20 minutes in Wash I (pre-warm to 600C) at 6O0C with
shaking
- Wash three times for 20 minutes in Wash II (pre-warm to 600C) at 600C with
shaking
- Wash twice for 1 0 minutes in TBST at room temperature with shaking
- Block for 1 hour in 20% heat inactivated sheep serum/TBST at room temperature
with shaking
Pre-absorb antibody with chicken powder:
a. Combine 1 ml 20% inactivated serum/TBST and lui of Anti-Digoxigrnin-
AP (Roche 12930021) and a tiny amount of embryo powder in an
eppendorftube.
b. Shake tube.
c. Let the powder settle for five minutes on ice.
d. Remove the antibody and add it to the rest of the 20% inactivated
serum/TBST to make the correct dilution (1 µ? Presorbed a-DIG-AP in 10
ml with 20%o Inactivated Serum/TBST)
Placed embryos in the pre absorbed antibody solution overnight at 40C with
shaking
Day 4: Background reduction
Wash Embryos:
- Wash three times for 30 minutes in TBST at room temperature with shaking
- Wash three times for 1 hour in TBST+ 2mM Levamisole at 40C with shaking
- One overnight wash in TBST + 2mM Levamisole at 40C with shaking
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Day 5: Colour Detection
- Wash twice for 20 minutes in NTMT + 2mM Levamisole at room temperature
with shaking
- Dissolve one Sigma fast NBT-BCIP tablet in 1 0 mL of 1 0% PVA in NTMT.
- Incubate embryos in dark at room temperature with the NBT-BCIP solution until
developed (usually between 24 and 36 hours)
- Wash twice for 1 0 minutes in PBST + 5mM EDTA at room temperature
- Postfix with 4% PFA for 20 minutes at RT, no shaking
- Wash twice for 10 minutes in IXPBST at room temperature, no shaking
Dehydrate embryos in graded methanol
1. 15 minutes in 25:75 MeOH/lX PBST on ice (i.e. 25% methanol)
2. 1 5 minutes in 50:50 MeOH/PBS on ice (i.e. 50% methanol)
3 . 15 minutes in 75 :25 MeOH/depc H20 on ice (i.e. 70% methanol)
- Leech background from embryos in 90% MeOH O/N at 40C no shaking
Day 6: Storage
Place in 50:50 glycerol:water, store at 40C
In situ hybridization recipes
PBST 50OmIlOX
137mMNaCl 137ml5M
2.7mM KCl 3.37 ml 4M
4.3mM Na2HPO4 2 1 .5 ml 1 M
1.4mM KH2PO4 7 ml IM
0.1% Tween-20(Sigma P9416) 5 ml
0.01% DepC treated
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Proteinase K stock (lOmg/ml) lml






50µg/mL yeast tRNA (Roche 70132220) - add fresh
50µg/mL heparin (Sigma H3393) - add fresh
250 ml of 100% stock (ISC BioExpress 0606)
125 ml 2OX stock (Sigma S6639)








40 ml 2OX stock
20 ml 20% stock









2.7mMKCl 3.37 ml 4M
2.5mM Tris-Cl ph 7.5 125 ml IM
0.1%Tween-20 0.5 ml
0.01% DepC treated
NTMT 250 ml IX
10OmMNaCl 5 ml 5M
10OmM Tris-Cl pH 9.5 25 ml IM
20mMMgC12 5 ml IM
0.1%Tween-20 250 µ?
0.0 1 % DepC treated H20 2 1 5 ml
10% Hydrogen Peroxide/PBST (make fresh) 75 ml
25 ml 30% Hydrogen Peroxide (Sigma H1009) + 50 ml 1Ox PBST
4% PFA/PBST + 0.25% glutaraldehyde/PBST (50:50) 10 ml
50 µ? 25% glutaraldehyde (Sigma G5882) in 5 ml PBST + 5 ml 4% PFA/PBST
20% sheep serum/TBST 20 ml
4 ml sheep serum + 16 ml TBST
Heat inactivated for 30 minutes at 6O0C
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Chick Powder
Collect four 4-5 day embryos (HH stage 23-26) in a minimum amount of PBS.
Add 4 volumes of cold acetone and incubate on ice for 30 minutes.
Spin at 10000 RPM for 10 minutes and pour off the acetone.
Pour the embryos out onto clean filter paper and cut or crush them into a powder.
Store in the fridge
NBT/BCIP in 10%PVA in NTMT 10ml
1 g Polyvinyl Alcohol (Sigma 348406) in 10 ml NTMT
When 10% PVA in NTMT is cooled to room temperature; dissolve 1 tablet of Sigma
fast NBT-BCIP per 10 ml 10% PVA
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